Analysis BioNTech’s Spinoff Deadline Nears as ASCO Data Bolster Oncology Pipeline
The countdown is on for BioNTech’s founders, Ugur Sahin and Özlem Türeci, with binding contracts for a new mRNA-focused biotech venture expected to be signed by the end of June....